| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 91.441 | 103.028 | 91.231 | 90.604 | 91.665 | 81.259 | 81.371 | 79.796 | 79.415 | 67.053 |
| Total Income - EUR | 91.801 | 103.323 | 91.271 | 90.604 | 91.665 | 81.275 | 82.956 | 79.807 | 79.415 | 67.053 |
| Total Expenses - EUR | 90.805 | 97.011 | 89.089 | 81.723 | 85.516 | 80.438 | 81.654 | 79.971 | 80.239 | 70.945 |
| Gross Profit/Loss - EUR | 996 | 6.312 | 2.181 | 8.881 | 6.149 | 837 | 1.302 | -164 | -824 | -3.892 |
| Net Profit/Loss - EUR | 833 | 4.441 | 1.301 | 7.975 | 5.232 | 88 | 472 | -822 | -1.602 | -3.892 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Duoprim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.196 | 1.811 | 3.248 | 2.649 | 2.071 | 1.780 | 2.730 | 2.585 | 2.129 | 1.671 |
| Current Assets | 16.097 | 21.554 | 19.635 | 38.915 | 20.424 | 18.443 | 37.509 | 21.705 | 27.234 | 38.474 |
| Inventories | 6.677 | 6.524 | 11.135 | 16.397 | 8.201 | 5.336 | 23.907 | 9.774 | 13.527 | 23.787 |
| Receivables | 8.108 | 11.627 | 8.125 | 9.085 | 9.321 | 10.182 | 12.968 | 10.239 | 9.971 | 10.816 |
| Cash | 1.313 | 3.403 | 375 | 13.433 | 2.903 | 2.925 | 634 | 1.692 | 3.736 | 3.871 |
| Shareholders Funds | 9.587 | 13.930 | 14.996 | 10.607 | 11.197 | 4.544 | 5.022 | 3.789 | 1.955 | -1.948 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.706 | 9.435 | 7.886 | 30.957 | 11.298 | 15.679 | 35.218 | 20.501 | 27.408 | 42.093 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4531 - 4531" | |||||||||
| CAEN Financial Year |
4531
|
|||||||||
Comments - Duoprim Srl